Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Revenue (2023 - 2024)

Praxis Precision Medicines (PRAX) has 2 years of Revenue data on record, last reported at $7.5 million in Q4 2024.

  • For Q4 2024, Revenue rose 1349.13% year-over-year to $7.5 million; the TTM value through Sep 2025 reached $7.5 million, up 364.98%, while the annual FY2024 figure was $8.6 million, 249.53% up from the prior year.
  • Revenue reached $7.5 million in Q4 2024 per PRAX's latest filing, up from $302000.0 in the prior quarter.
  • Across five years, Revenue topped out at $7.5 million in Q4 2024 and bottomed at $302000.0 in Q3 2024.